S100A8 and neoplasm: Reduced the proportion of GMDSCs in the spleens of tumor-bearing mice., increased the level of ROS reaching toxic threshold level in G-MDSCs, decreased the expression of arginase 1, S100A8, and S100A9, inhibited tumor growth